Inhibition of AKT by other pharmacological drugs also promotes the clearance of aggregated material in a variety of models of lysosomal storage diseases [21], suggesting that trehalose is not only capable of activating TFEB and mitochondria elongation, but also promotes the clearance of lysosomal aggregated material. The gene discussed is TFEB; the disease is lysosomal storage disease.